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WUPyV in Children 
with Acute 
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Infections, China
To the Editor: WU polyomavirus 
(WUPyV) is a human polyomavirus 
ﬁ   rst detected in respiratory samples 
in 2007 (1). It has since been detect-
ed worldwide (2–7), including the 
People’s Republic of China (8), but 
whether it is a causative respiratory 
pathogen remains speculative. To in-
vestigate the potential role of WUPyV 
in respiratory diseases and its preva-
lence in Tianjin, China, we examined 
samples obtained from children with 
upper respiratory tract infections (UR-
TIs) and lower respiratory tract infec-
tions (LRTIs) by using PCR for the 
VP2 and LTAg genes, as described 
previously (1). As a control, we also 
tested samples from patients who did 
not have respiratory diseases. 
Case-patients were 174 inpatients, 
hospitalized for LRTIs March–April 
2008 and September 2008–February 
2009, and 68 outpatients treated for 
URTIs November–December 2009 at 
Tianjin Children’s Hospital. Controls 
were 43 outpatients with illnesses 
other than respiratory diseases treated 
at Tianjin Xianshuigu Hospital. Most 
patients with LRTIs had pneumonia 
or bronchitis. Case-patient age ranged 
from 3 hours to 12 years; for 1 patient, 
age was unknown (Table). Nasopha-
ryngeal aspirate samples were col-
lected from hospitalized children, and 
throat swabs were obtained from out-
patients with URTIs and from control 
children.
Of the 174 nasopharyngeal aspi-
rate specimens tested, 28 (16%) had 
WUPyV VP2 gene–positive frag-
ments; 24 had LTAg gene–positive 
fragments. Four VP2-positive but 
LTAg-negative fragments were se-
quenced; nucleotide sequences were 
identical to WUPyV strains in Gen-
Bank. Mean age of WUPyV-infected 
patients was 11.7 months (range 12 
days–39 months); 10 patients (36%) 
were <6 months of age, 10 (36%) 
were 6 months–1 year, 7 (25%) were 
1–2 years, and 1 (4%) was 2–5 years 
of age. The age distribution was simi-
lar to that of the original cohort. We 
found WUPyV-positive samples in 
most months, except for March 2008. 
Highest proportion of WUPyV-pos-
itive samples occurred in December 
2008 (27%), followed by April 2008 
(25%), November 2008 (22%), and 
February 2009 (19%).
We detected WUPyV VP2 frag-
ment–positive specimens by multi-
PCR using the Seeplex RV Detection 
kit-1 (Seegene, Seoul, South Korea) 
for other respiratory viruses, includ-
ing adenovirus, parainﬂ  uenza viruses 
1, 2, 3 (PIV1, 2, 3), inﬂ  uenza viruses 
A and B, rhinovirus (rhinovirus V), 
human metapneumovirus, respiratory 
syncytial virus A and B (RSV A, B), 
and coronaviruses OC43/HKU1 and 
229E/NL63, according to the manu-
facturers’ instructions. First strands 
of cDNA were produced by using the 
RevertAid First Strand cDNA Synthe-
sis Kit (Fermentas, Glen Burnie, MD, 
USA). Human bocavirus (HBoV) was 
tested as described previously (9).
Twenty (71%) case-patients were 
co-infected with other respiratory vi-
ruses, most commonly RSV B (9/28, 
32%), followed by HBoV (6/28, 21%), 
rhinovirus V and PIV3 (4 each of 28, 
14%), human metapneumovirus (3/28, 
11%), adenovirus and inﬂ  uenza A (2 
each of 28, 7%), and 229E (1/28, 4%). 
Of 20 patients with co-infections, 14 
(50%) were infected with 2 viruses; 
2 (7%) with 3 viruses (WU, RSV B, 
PIV3; and WU, inﬂ  uenza  virus,  A, 
HBoV); 3 (11%), with 4 viruses (WU, 
RSV B, PIV3, inﬂ  uenza A; WU, RSV 
B, PIV3, HBoV; and WU, RSV B, rhi-
novirus V, HBoV); and 1 (4%), with 
5 viruses (WU, RSV B, PIV3, BoV, 
rhinovirus V).
Three (4%) of 68 throat swabs 
from outpatients with URTIs were 
WUPyV positive, substantially low-
er than from inpatients with LRTIs. 
Among 3 WUPyV-positive case-
patients, 2 were 2 years of age and 1 
was 3. No WUPyV was detected in 43 
control samples.
The prevalence of WUPyV in 
hospitalized children with acute respi-
ratory tract infections in Tianjin was 
16.1%, higher than 7.1% found in a 
study in the United States (3); 4.9% 
in Germany (4); 4.5% in Australia 
(5); 6.29% in Thailand (6); and 2.2% 
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Table. Age distribution of children infected with WU polyomavirus, Tianjin, People’s 
Republic of China, 2008–2009* 
Age
Inpatients with 
LRTIs
Outpatients with 
URTIs 
Children without 
respiratory diseases 
Mean ± SD, y  10.2 ± 16.1  5.96 ± 3.69  7.56 ± 4.25 
Median age, y 0.4 5.0 7.0
Age group 
  <6 mo  95 (54.6)  1 (1.5)  0
  6 mo–<1 y  52 (29.9)  1 (1.5)  0
  1–<2 y  15 (8.6)  3 (4.4)  2 (4.6) 
  2–5 y  9 (5.2)  25 (36.8)  11 (25.6) 
  >5 y  2 (1.1)  38 (55.9)  30 (69.8) 
 Unknown  1  (0.6)  0 0
Total 174 (100.0)  68 (100.0)  43 (100.0) 
* LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections. Values are no. 
(%) unless otherwise indicated.  LETTERS
in Lanzhou, China (8). Variation may 
be due to different geographic and 
age distributions of the virus. Anoth-
er study reported that frequencies of 
WUPyV in URTIs (6.7%) and LRTIs 
cases (7.1%) were comparable (10). 
However, we found the incidence 
of WUPyV in patients with LRTIs 
(16.1%) was higher than in patients 
with URTIs (4.4%). Among WUPyV-
infected patients with LRTIs, 71.4% 
were <1 year of age, which was com-
parable to populations investigated in 
other studies (2,3,6). Although ≈60% 
of outpatients with URTIs were >5 
years of age, none was WUPyV posi-
tive. This ﬁ  nding  suggests  WUPyV 
may play a major role in young chil-
dren, especially infants, with LRTIs.
Most WUPyV infection has been 
detected during later winter and early 
spring (2,4,5) although other research 
showed no seasonal distribution (6). 
We found 2 peaks, in April and De-
cember 2008 (L. Xiaoyan et al., unpub. 
data). We also detected 1 WUPyV-in-
fected case in September 2008, which 
suggests WUPyV could also occur in 
summer months.
Frequency of WUPyV co-infec-
tion with other pathogens varied from 
42.1% to 79.7% (4–6). Although we 
showed a co-infection rate of 71.4%, 
there were 8 (28.6%) of 28 patients 
with respiratory illness in whose 
specimens we detected only 1 virus, 
WUPyV. No WUPyV was detected 
in samples from 43 control patients, 
whereas in patients with LRTIs and 
URTIs, infection rates were 16.1% 
and 4.4%, respectively. These ﬁ  nd-
ings suggest WUPyV may be a po-
tential pathogenic agent in children 
with acute respiratory tract infections. 
More comprehensive case–control in-
vestigations are needed to determine 
the association of WUPyV infections 
with respiratory diseases.
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Intestinal 
Capillariasis, 
Western Mindanao, 
the Philippines 
To the Editor: Capillariasis is 
caused by the foodborne nematode 
Capillaria philippinensis. Infection 
causes severe diarrhea and protein loss 
resulting in dehydration, cachexia, 
and eventually death. Infected patients 
may also have borborygmi, abdominal 
pain, weight loss, anorexia, vomiting, 
and bipedal edema (1).
C. philippinensis was ﬁ  rst report-
ed in 1963 in Bacarra, Ilocos Norte 
Province in the northern Philippines 
(2). Since then, additional endemic 
foci of C.  philippinensis have been 
identiﬁ  ed. The most recent focus is in 
Monkayo, Compostela Valley, in the 
southern Philippines (3). In the past 
several years, suspected unconﬁ  rmed 
cases have been reported from Zam-
boanga del Norte Province in western 
Mindanao. In 1999, an epidemic of 
gastroenteritis in Piñan Municipality 
was reported; it resulted in 42 deaths. 
The schistosomiasis team of the De-
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